Exchange: NASDAQ·Updated 07:58 PM EST
NRXP logo

NRXP NRX Pharmaceuticals Inc

$2.15
$0.40
(15.69%)
Today
Closed $2.15
$0.0793
(3.69%)
After Hours
Reported EarningsNov 17
Mkt Cap$95.31M
Vol1.48M

About NRXP

NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded by Jonathan C. Javitt on September 18, 2017 and is headquartered in Wilmington, DE.
67

Bullish Sentiment

How do you feel about NRXP?

Advertisement|Remove ads.